CD274 and neoplasm: Similarly, antibiotic administration was reported to reduce the diversity and aggravate dysbiosis of the gut microbiome, thus influencing the clinical response to PD-1/PD-L1 blockade in tumor-bearing mice as well as cancer patients [60–62]..